Literature DB >> 23781679

Eight cases of bladder cancer in pioglitazone users from India.

Ranjit Unnikrishnan, Chandru Sundramoorthy, Neeta Deshpande, R Sarvothaman, Rakesh Kumar Sahay, Suresh Mehtalia, Janarthanan Vijay Venkatraman, Viswanathan Mohan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23781679

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN： 0004-5772


× No keyword cloud information.
  5 in total

1.  Development of vascular complications and bladder carcinoma in diabetics using pioglitazone: A five-year Indian review.

Authors:  Saarwaani Vallabhajosyula; Shashaank Vallabhajosyula; Saraschandra Vallabhajosyula; Suma Nair; Asha Kamath; Karthik N Rao
Journal:  Med J Armed Forces India       Date:  2016-08-09

2.  Pioglitazone suspension and its aftermath: A wake up call for the Indian drug regulatory authorities.

Authors:  Arif Hashmi
Journal:  J Pharmacol Pharmacother       Date:  2013-10

3.  Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study.

Authors:  Aman Goyal; Harmanjit Singh; Vijay Kumar Sehgal; C R Jayanthi; Renuka Munshi; K Laxminarayana Bairy; Rakesh Kumar; Sandeep Kaushal; Ashish Kumar Kakkar; Sneha Ambwani; Chhaya Goyal; Goutameswar Mazumdar; Anjan Adhikari; Nina Das; Divya John Stephy; Pugazhenthan Thangaraju; D C Dhasmana; Shakil U Rehman; Amit Chakrabarti; Basavaraj Bhandare; Dinesh Kumar Badyal; Inderpal Kaur; K Chandrashekar; Jagjit Singh; Puneet Dhamija; Sudhir Chandra Sarangi; Yogendra Kumar Gupta
Journal:  Indian J Med Res       Date:  2017-10       Impact factor: 2.375

Review 4.  Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report.

Authors:  Sarayu A Pai; Nilima A Kshirsagar
Journal:  Indian J Med Res       Date:  2016-11       Impact factor: 2.375

5.  A retrospective study to assess the risk of bladder cancer in type-2 diabetic patients treated with pioglitazone.

Authors:  Prabhat Agrawal; Apoorva Jain; Ashish Gautam; Ashwini Kumar Nigam; Nikhil Pursnani; Maaz Farooqui
Journal:  Perspect Clin Res       Date:  2019-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.